Hello! My greetings and good wishes to all TED'ies. I have been following this forum for quite sometime. I think it's a great forum and finally I have decided to jump in. I would like to start by asking my fellow members about their thoughts on Ranbaxy labs. I have held it for about a decade. It is resting at the current levels for the last three years and have been waiting for it to recover to 600 odd levels as before.Now that it is showing no such signs,  I am debating whether to swap it with a retail or entertainment stock at this point of time.

In April, the Serious Fraud Office of United Kingdom announced that it would initiate legal action against certain individuals and five companies who had conspired to defraud the National Health Services over supply and pricing of drugs. Ranbaxy is one of the five companies allegedly involved in the matter. In these circumstances we cannot expect any positive response from the market with regard to Ranbaxy 

One should also consider the subsidiaries of Ranbaxy - Fortis healthcare and Religare securities. Religare is very aggressive in the market and should be able to add significantly to the bottom line of Ranbaxy - not to mention the value unlocking potential a few years down the line.

The market cap of these subsidiaries (Religare is not listed) are insignificant to the market cap of Ranbaxy so in this case it is better to buy the subsidiaries if you get a chance.